Lynch & Associates Buys Dow Inc, JPMorgan Chase, Berkshire Hathaway Inc, Sells iShares Russell Mid-Cap, Navidea Biopharmaceuticals Inc

• New Purchases: CVS, 6D81,
• Added Positions: DOW, JPM, BRK.B, USB, GIS, T, IBM, AAPL, DUK, IJR, LMT, ITOT, FTEC, FHLC, EMR, RDS.A, IXUS, AEP, IEMG, CINF, FCF,
• Reduced Positions: WBA, MSFT, WFC, IJH, PM, INTC, HON, GILD, BP, MRK, UTX, SYK, LOW, BMY, MO, IP, TJX, ITW, GE, MMM,
• Sold Out: IWR, NAVB,

For the details of LYNCH & ASSOCIATES's stock buys and sells, go to https://www.gurufocus.com/guru/lynch+%26+associates/current-portfolio/portfolioportfolio

1. Microsoft Corp (MSFT) - 151,381 shares, 6.68% of the total portfolio. Shares reduced by 2.4%
2. Johnson & Johnson (JNJ) - 98,329 shares, 4.51% of the total portfolio. Shares reduced by 0.5%
3. iShares Core S&P 500 (IVV) - 38,721 shares, 3.76% of the total portfolio. Shares reduced by 0.84%
4. Procter & Gamble Co (PG) - 102,717 shares, 3.71% of the total portfolio. Shares reduced by 0.95%
5. iShares Core S&P Mid-Cap (IJH) - 56,432 shares, 3.61% of the total portfolio. Shares reduced by 1.39%

Lynch & Associates initiated holding in CVS Health Corp. The purchase prices were between $52.13 and $57.33, with an estimated average price of $53.82. The stock is now traded at around $56.31. The impact to a portfolio due to this purchase was 0.17%. The holding were 9,420 shares as of .

Lynch & Associates initiated holding in DuPont de Nemours Inc. The purchase prices were between $58.22 and $146.52, with an estimated average price of $85.68. The stock is now traded at around $63.66. The impact to a portfolio due to this purchase was 0.11%. The holding were 4,479 shares as of .

Lynch & Associates added to a holding in Dow Inc by 119.30%. The purchase prices were between $46.76 and $59.71, with an estimated average price of $52.82. The stock is now traded at around $51.70. The impact to a portfolio due to this purchase was 0.78%. The holding were 88,225 shares as of .

Lynch & Associates added to a holding in JPMorgan Chase & Co by 33.89%. The purchase prices were between $104.64 and $116.12, with an estimated average price of $110.3. The stock is now traded at around $114.47. The impact to a portfolio due to this purchase was 0.34%. The holding were 37,051 shares as of .

Lynch & Associates added to a holding in Berkshire Hathaway Inc by 162.97%. The purchase prices were between $197.42 and $218.6, with an estimated average price of $206.89. The stock is now traded at around $207.10. The impact to a portfolio due to this purchase was 0.31%. The holding were 7,116 shares as of .

Lynch & Associates added to a holding in General Mills Inc by 50.30%. The purchase prices were between $48.25 and $54.02, with an estimated average price of $51.69. The stock is now traded at around $53.25. The impact to a portfolio due to this purchase was 0.12%. The holding were 21,065 shares as of .

Lynch & Associates added to a holding in Apple Inc by 29.87%. The purchase prices were between $173.3 and $211.75, with an estimated average price of $194.79. The stock is now traded at around $204.98. The impact to a portfolio due to this purchase was 0.03%. The holding were 2,174 shares as of .

Lynch & Associates sold out a holding in iShares Russell Mid-Cap. The sale prices were between $52.35 and $56.11, with an estimated average price of $54.7.

Lynch & Associates sold out a holding in Navidea Biopharmaceuticals Inc. The sale prices were between $0.62 and $3.6, with an estimated average price of $1.96.